TURKEY – CERTAIN MEASURES CONCERNING THE PRODUCTION,
IMPORTATION AND MARKETING OF PHARMACEUTICAL PRODUCTS

Status Report by Türkiye

Addendum

The following communication, dated 19 May 2023, from the delegation of Türkiye to the Chairperson of the Dispute Settlement Body, is circulated at the request of that delegation.

_______________

STATUS REPORT REGARDING IMPLEMENTATION OF THE
RECOMMENDATIONS AND RULINGS BY TÜRKİYE

Türkiye submits this status report under Article 21.6 of the Understanding on Rules and Procedures Governing the Settlement of Disputes (DSU) to inform the Dispute Settlement Body (DSB) of its progress in the implementation of the arbitration award in DS583.

Türkiye wishes to refer to its previous report (WT/DS583/18) and would like to inform the DSB that the new Alternative Drug Reimbursement Regulation was published in the Official Gazette on 12 May 2023. The new regulation fully respects Türkiye's WTO obligations.

Türkiye stands ready to respond to the questions the European Union may have in relation to the implementation in this dispute.